r VRX Stock Quote - Valeant Pharmaceuticals International Inc Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

Valeant Pharmaceuticals International Inc
(NYSE : VRX)

( )
VRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.44%165.230.4%$265.05m
VRXValeant Pharmaceuticals International, Inc.
0.07%22.2414.1%$212.97m
PRGOPerrigo Co. Plc
0.16%75.236.7%$104.96m
JAZZJazz Pharmaceuticals Plc
0.88%165.022.2%$90.98m
PTLAPortola Pharmaceuticals, Inc.
2.15%40.877.7%$78.49m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.71%161.107.6%$65.70m
SAGESAGE Therapeutics, Inc.
-1.80%155.339.6%$59.08m
MNKMallinckrodt Plc
0.37%16.5021.1%$57.14m
SUPNSupernus Pharmaceuticals, Inc.
2.88%57.256.3%$49.46m
PBHPrestige Brands Holdings, Inc.
2.21%34.653.8%$41.61m
UTHRUnited Therapeutics Corporation
-1.08%103.6014.4%$36.84m
HZNPHorizon Pharma plc
4.19%16.177.5%$32.52m
CTLTCatalent Inc
0.13%38.862.6%$31.49m
ICPTIntercept Pharmaceuticals, Inc.
1.88%71.0721.8%$31.38m
ENDPEndo International Plc
0.80%6.318.9%$29.93m

Company Profile

Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment refers to the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.